UCB, a global biopharmaceutical company, today presented positive efficacy and safety results from the GEMZ phase 3 study ...
The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group, focused ...
"Instead of chocolates, the Disney+ Perks program is dropping a new offer every single day between December 1 and December 12 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results